All stock lists
Janus Living, Inc. (New York Stock Exchange:JAN)
US · Delayed Price · Currency is USD
Real Estate · REIT - Diversified
$31.82-$0.33 (-1.03%)
Market cap
$7.46B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 20, 2026
Website
Insider Score
––Not scored
JAN Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From JAN’s reported statements · Q3 2026 (trailing 12 months)
Profitability9 / 20
Loses money on what it sells.
- Revenue
- $1.01B
- Net income
- -$20.1M
- Net margin
- -2.0%
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $338.1M
- Net debt / EBITDA
- -1.00x
Liquidity3 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $521.6M
- Current liabilities
- $718.4M
- Current ratio
- 0.73
Cash generation9 / 20
Roughly cash-neutral.
- Operating cash flow
- $42.8M
- Free cash flow
- -$34.3M
- FCF margin
- -3.4%
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 302.2M
- Share growth (1y)
- 67.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
JAN Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Mar 19, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $268.30 M | $216.46 M | $200.34 M | $322.93 M | $148.85 M | $148.93 M |
| Revenue Growth (YoY) | 80.24 % | 45.34 % | — | — | — | — |
| Cost of Revenue | $350.78 M | $271.73 M | $247.39 M | $0.00 | $0.00 | $0.00 |
| Gross Profit | -$82.48 M | -$55.28 M | -$47.05 M | $322.93 M | $148.85 M | $148.93 M |
| SG&A Expense | $1.53 M | $1.33 M | $0.00 | $6.93 M | $2.38 M | $3.13 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | -$69.98 M | -$48.39 M | -$48.11 M | $425.70 M | $145.36 M | $146.57 M |
| Operating Income | -$12.51 M | -$6.89 M | $1.06 M | -$102.78 M | $3.50 M | $2.36 M |
| Pretax Income | -$4.72 M | $13.11 M | $29.00 M | -$71.69 M | -$474.00 K | $481.00 K |
| Tax Provision | $891.00 K | $1.75 M | $1.12 M | $11.83 M | $2.10 M | $2.59 M |
| Net Income | -$4.32 M | $10.72 M | $31.33 M | -$57.83 M | -$2.57 M | -$2.11 M |
| EPS (Basic) | -$0.02 | $0.06 | -$0.05 | $0.00 | -$0.01 | -$0.01 |
| EPS (Diluted) | -$0.02 | $0.05 | -$0.05 | $0.00 | -$0.01 | -$0.01 |
| Shares Outstanding | 302.25 M | 195.01 M | 187.22 M | 0.00 | 180.92 M | 180.92 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.